Cryoport Systems - CYRX Expected earnings per share growth for next year

The projected change in earnings per share for the coming year on the GURU.Markets consolidated chart shows that 22.30 forms the current metric. This results from Cryoport, Inc. (CYRX) management adapting capacities to market demand. Cryoport, Inc. (CYRX) maintains its leadership in the gene therapy cold chain by utilizing smart containers, while IoT solutions with cloud AI fully automate the temperature control of biomaterials.

Cryoport Systems (CYRX): Expected net earnings per share growth next year from 07/04/2022 to 11/14/2026

Metric breakdowns and analytics for Cryoport Inc (CYRX)

- price and consensus price forecast:

Price Chart Cryoport, Inc.|CYRX - Fair Value Consensus

- issuer market value details:

Market Valuation Cryoport|CYRX - Total Enterprise Value

- book capitalization information:

Net Assets per Single Share Cryoport|CYRX - Total Stockholders' Equity|Market Value to Book Value Ratio cryoport.com|CYRX - Total Asset Value of Company

- issuer credit burden and liquidity indicators:

- net income and valuation ratios data:

CYRX - Net Financial Result|Expected Profit Cryoport, Inc.|CYRX - Price to Earnings Multiple|Forward P/E Multiple Cryoport Inc|CYRX - Price/Earnings to Growth Multiple|Enterprise Value to EBITDA Ratio Cryoport Corp|CYRX - Operating income before deduction of amortization|Net earnings per share (EPS TTM) Cryoport|CYRX - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months cryoport.com|CYRX - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Cryoport, Inc.

- total revenue and sales volume data:

CYRX - Company Sales Revenue|Company Future Sales Volume Cryoport|CYRX - Market Cap to Revenue Ratio|Price-to-Projected Revenue Ratio Cryoport Inc

Fundamental company valuation:Cryoport Systems

This indicator is calculated as the percentage deviation of the expected net earnings per share for the following year from current values, providing a real-time assessment of analysts' model revisions. The metric serves as a filter for market noise, ensuring a continuous evaluation of the issuer's fundamental potential between quarterly reports. For Cryoport, Inc. (CYRX), this growth is driven by the implementation of sustainable reusable cooling systems that reduce costs and waste volume. By analyzing the forward EPS growth forecast, an investor assesses the efficiency of this technological transformation.

Direct competitors